home / stock / lobe:cc / lobe:cc news


LOBE:CC News and Press, Lobe Sciences Ltd. From 06/06/22

Stock Information

Company Name: Lobe Sciences Ltd.
Stock Symbol: LOBE:CC
Market: CNQC
Website: lobesciences.com

Menu

LOBE:CC LOBE:CC Quote LOBE:CC Short LOBE:CC News LOBE:CC Articles LOBE:CC Message Board
Get LOBE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

LOBE:CC - Lobe Sciences Announces Share Consolidation

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (" Lobe " or the " Company ") announces that its board of directors has authorized the implementation of a consolidation (the " Consolidation ") of the Company's common shares (the " Sh...

LOBE:CC - KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27 th and 28 th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing....

LOBE:CC - KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences , the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Co...

LOBE:CC - Lobe Sciences Ltd. to Webcast Live at VirtualInvestorConferences.com April 27th

VANCOUVER, British Columbia, April 25, 2022 (GLOBE NEWSWIRE) -- Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), based in Canada, a life sciences company focused on psychedelic medicines today announced that Philip Young, CEO, will present live at Virtua...

LOBE:CC - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) Featured in Coverage of Planet MicroCap's Virtual Investor Conference

Lobe Sciences (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") is biotechnology company entering clinical stage development this year and is focused on transforming psychedelic medicine to benefit patients of all ages. Lobe is engaged in research and development using psychedelic and n...

LOBE:CC - Lobe Sciences Ltd. to Participate in the Lytham Partners Spring 2022 Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. The Company'...

LOBE:CC - Lobe Sciences Ltd. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th - 30th from 9:00 A.M. - 5:00 P.M. EDT

Vancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (" Lobe " or the " Company ") announced today that Philip Young, CEO, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-V...

LOBE:CC - Lobe Sciences to Present at MONEYSHOW VIRTUAL EXPO March, 23 2022

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2022) -  Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (" Lobe " or the " Company ") today announced that Philip Young, CEO and Director, will present at the MONEYSHOW VIRTUAL EXPO, March 23 rd at 11:30AM EST. The presentatio...

Previous 10 Next 10